Partnerships are very important to us

Therapeutics
We are taking our first therapeutic programs forward through Phase 2 clinical trials but aim to develop these programs further with partners who provide funding or access to complementary skill sets.

Plant Agriculture
We have an exclusive commercial license agreement with Dow AgroSciences who is using our ZFP technology to improve crop plants such as maize and canola and marketing the technology for use in plants under the trademark ExZact Precision Technology. To find out more, please click here.

Research Reagents
We have an exclusive commercial license agreement with Sigma-Aldrich Corporation for the use of technology in research applications. Sigma is marketing ZFP reagents under the trademark CompoZr. To find out more, please click here.

Collaborations in Enabling Technologies
Our Enabling Technology Agreements allow us to leverage our technology and provide near to mid term revenue.
Opportunities:

• ZFP TF- and ZFN-Engineered Cell Lines for the Manufacturing of Protein Pharmaceuticals.
  • Genentech
  • Amgen
  • Pfizer
• ZFNs for the Development of Transgenic Animals. We have existing agreements with:
  
  • Open Monoclonal Technology, Inc.
  • Hoffman-La Roche
  
  back to top